Showing results 1 to 20 of 50  next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2008JRC45708213Bi (Alpha-emitter)-Antibody Targeting of Breast Cancer Metastases in the neu-N Transgenic Mouse ModelSONG H.; SHAHVERDI K.; HUSO D. L.; ESAIAS C.; FOX J.; LIEDY A.; ZHANG Z.; REILLY R. T.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED, et alArticles in periodicals and books
2007JRC38225213bi-Induced Death of Hsc45-M2 Gastric Cancer Cells Is Characterized by G2 Arrest and Up-Regulation of Genes Known to Prevent Apoptosis but Induce Necrosis and Mitotic CatastrpopheSEIDL C.; PORT M.; GILBERTZ K.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHWAIGER M.; ROEPER B.; SENEKOWITSCH-SCHMIDTKE R.; ABEND M.Articles in periodicals and books
2007JRC41950213Bi-radioimmunotherapy Defeats Early-stage Disseminated Gastric Cancer in Nude MiceBECK R.; SEIDL C.; PFOST B.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BAUM M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2017JRC106139225Ac-DOTA-Substance P as a potential radiopharmaceutical for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA PILIP AGNIESZKA; RIUS MONTRAVETA MARIA; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; WEIS MIRJAM; BONELLI MILTON; LAURENZA MARTA; MORGENSTERN ALFREDArticles in periodicals and books
2017JRC106148225Ac-PSMA617: PSMA targeting alpha-radiation therapy of patients with mCRPCKRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; GIESEL FREDERIK; APOSTOLIDIS CHRISTOS; HABERKORN UWE; MORGENSTERN ALFREDArticles in periodicals and books
2006JRC33735Antibody-guided Alpha Radiation Effectively Damages Fungal BiofilmsMARTINEZ L.r.; BRYAN R.a.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; CASADEVALL A.; DADACHOVA E.Articles in periodicals and books
2017JRC106137Assessing 225Ac-Polymersomes for Targeted Radionuclide TherapyDE KRUIJFF R. M.; HESKAMP SANDRA; VAN DER MEER A; KOUWENBERG J; TORRELO VILLA G; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SMINIA P; DENKOVA A.G.Articles in periodicals and books
2017JRC105961Assessment of 213Bi-anti-EGFR-MAb treatment response in malignant cancer cellsFEUERECKER BENEDIKT; RANDL PHILIPP; SEIDL C.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SCHWAIGER M.; EISENREICH WOLFGANGArticles in periodicals and books
2017JRC105960Barium ferrite nanoparticles labeled with 223Ra: a new potential radiobioconjugate for internal alpha therapyMALISZEWSKA W; CĘDROWSKA E; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BILEWICZ ALEKSANDERArticles in periodicals and books
2017JRC106154Bi-213-anti-EGFR-MAb therapy of recurrent bladder cancer – a pilot studySCHEIDHAUER KLEMENS; SEIDL C.; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; AUTENRIETH MICHAEL; KURTZ F; HORN THOMAS; SCHWAIGER MARKUS; GSCHWEND J.E.; D'ALESSANDRIA C, et alArticles in periodicals and books
2017JRC106150Biodistribution, dosimetry and imaging of 225Ac-DOTA-anti-PD-L1-BC in a murine immunocompetent transgenic breast cancer modelJOSEFSSON ANDERS; NEDROW JESSIE; PARK SUNJU; BAECK TOM; HOBBS ROBERT F.; BRAYTON CORY; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.Articles in periodicals and books
2007JRC37152Breaking Chemo- and Radioresistance with [Bi-213]anti-CD45 Antibodies in Leukemia CellsFRIESEN C.; GLATTING G.; KOOP B.; SCHWARZ K.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; DEBATIN K.m.; RESKE S.n.Articles in periodicals and books
2006JRC35134Control of Prostate Cancer Spheroid Growth Using (213)Bi-labeled Multiple Targeted Alpha RadioimmunoconjugatesWANG J.; RIZVI S.m.a.; MADIGAN C.; COZZI P.j.; POWER C.a.; QU C.f.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; RUSSEL P.j.; ALLEN B.j., et alArticles in periodicals and books
2017JRC106151Correspondence between alpha-particle emitter dosimetry and normal organ toxicityJOSEFSSON ANDERS; NEDROW JESSIE; HOBBS ROBERT F.; BAECK TOM; PARK SUNJU; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS GEORGEArticles in periodicals and books
2005JRC30447Cyclotron Production of Ac-225 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; MOELLENBECK J.; MORGENSTERN ALFRED; ABBAS KAMELArticles in periodicals and books
2005JRC32186Cyclotron Production of Ac-225 for Targeted Alpha TherapyAPOSTOLIDIS CHRISTOS; MOLINET Roger; MCGINLEY JOHN; ABBAS KAMEL; MOELLENBECK J.; MORGENSTERN ALFREDArticles in periodicals and books
2008JRC44968The Cytokinesis-Block Micronucleus Assay as a Biological Dosimeter for Targeted Alpha TherapySONG E.; RIZVI S.; QU C. F.; RAJA C.; YUEN J.; LI Y.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J.Articles in periodicals and books
2006JRC33597Cytotoxicity of PAI2, C595 and Herceptin Vectors Labeled with the Alpha-Emitting Radioisotope Bismuth-213 for Ovarian Cancer Cell Monolayers and ClustersSONG Y.j.; QU C.f.; RIZVI S.m.a.; LI Y.; ROBERTSON G.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; PERKINS A.c.; ALLEN Barry J.Articles in periodicals and books
2008JRC44967Development and Evaluation of Peptidic Ligands Targeting Tumor-associated Urokinase Plasminogen Activator Receptor (uPAR) for Use in Alpha-emitter Therapy of Disseminated Ovarian CancerKNOER S.; SATO S.; HUBER T.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHMITT M.; KESSLER H.; SENEKOWITSCH-SCHMIDTKE R.; MAGDOLEN V.; SEIDL C.Articles in periodicals and books
2005JRC30250Fractionated Locoregional Low-Dose Radioimmunotherapy Improves Survival in a Mouse Model of Diffuse Type Gastric Cancer Using A 213BI-conjugated Monoclonal AntibodyBLOECHEL S.; BECK R.; SEIDL C.; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books